Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

Bibliographic Details
Main Authors:	Anouk W. M. A. Schaeffers, Lot A. Devriese, Carla H. van Gils, Jan Willem Dankbaar, Jens Voortman, Jan Paul de Boer, Marije Slingerland, Mathijs P. Hendriks, Ernst J. Smid, Geert W. J. Frederix, Remco de Bree
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681175/?tool=EBI

Internet